Should patients with GERD be screened once at least for Barrett's epithelium? PRO: The need to screen GERD patients for Barrett's esophagus - A greater yield than surveillance

American Journal of Gastroenterology

Volumn 99, Issue 12, 2004, Pages 2291-2293

  Sampliner, Richard E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE COURSE; EARLY DIAGNOSIS; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; PRACTICE GUIDELINE; PRECANCER; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; GASTROESOPHAGEAL REFLUX; HUMANS; MASS SCREENING; PRECANCEROUS CONDITIONS;

EID: 11144268905     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.41295_1.x     Document Type: Review

References (25)

1. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-56.
2. Eloubeide MA, Mason AC, Desmond RA, et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope? Am J Gastroenterol 2003;98(7):1627-33.
3. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 2002:26-33.
4. Lieberman DA, Oehlke M, Helfand M, et al. Risk factors for Barrett's esophagus in community-based practice. Am J Gastroenterol 1997;92(8):1293-7.
5. Eisen GM, Sandier IS, Murray S, et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997;92:27-31.
6. Breslin NP, Thompson ABR, Bailey RJ, et al. Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia. Gut 2000;46:93-7.
7. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
8. Chak A, Lee T, Kinnard MF, et al. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002;51:323-8.
9. Eloubeide MA, Provenzale D. Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease. J Clin Gastroenterol 2001;33(4):306-9.
10. Gerson LB, Edson R, Lavori PW, et al. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol 2001;96:2005-12.
11. Avidan B, Sonnenberg A, Schnell TG, et al. There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: Endoscopic diagnosis is still essential. Aliment Pharmacol 2002;16:735-42.
12. Conio M, Filiberti R, Blanchi S, et al. Risk factors for Barrett's esophagus: A case-control study. Int J Cancer 2002;97:225-9.
13. Sampliner RE, Practice Parameters Committee ACG. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
14. Soni A, Sampliner RE, Sonnenberg A. Screening for high grade dysplasia in gastroesophageal reflux disease: Is it cost effective? Am J Gastroenterol 2000;95:2086-93.
15. Nietert PJ, Silverstein MD, Mokhashi MS, et al. Cost-effectiveness of screening a population with chronic gastroesophageal reflux. Gastrointest Endosc Clin N Am 2003;57:311-8.
16. Dattamajumdar AK, Blount P, Myers JA, et al. A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma. Trans Biomed Eng 2001;48(6):695-704.
17. Falk GW, Ours TM, Richter J. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 2000;52:197-203.
18. Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol 2003;17:1319-24.
19. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus-A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92(2):212-5.
20. Shaheen NJ, Crosby MA, Bozymski EM. Is there publication bias in the reporting of cancer risk of Barrett's esophagus? Gastroenterology 2000;119:333-8.
21. Sharma P, Reker D, Falk GW, et al. Progression of Barrett's esophagus to high grade dysplasia and cancer: Preliminary results of the BEST (Barrett's esophagus study) trial (abstract). Gastroenterology 2001;120(79):A16-7.
22. Inadomi JM, Sampliner RE, Lagergren J, et al. Screening and surveillance for Barrett's esophagus in high-risk groups: A cost-utility analysis. Ann Intern Med 2003;138(3):176-86.
23. Rabeneck L, Wristers K, Souchek J, et al. Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia. Gastrointest Endosc Clin N Am 2003;2003:295-9.
24. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
25. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340(11):825-31.